Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy

BACKGROUND: The prognostic and predictive value of multiple serum biomarkers was evaluated using samples from a randomised phase III study (HORIZON II) investigating chemotherapy with or without cediranib in metastatic colorectal cancer (mCRC). METHODS: Baseline levels of 207 protein markers were me...

Descripción completa

Detalles Bibliográficos
Autores principales: Spencer, S K M, Pommier, A J C, Morgan, S R, Barry, S T, Robertson, J D, Hoff, P M, Jürgensmeier, J M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844909/
https://www.ncbi.nlm.nih.gov/pubmed/24149180
http://dx.doi.org/10.1038/bjc.2013.649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844909/
https://www.ncbi.nlm.nih.gov/pubmed/24149180
http://dx.doi.org/10.1038/bjc.2013.649

Ejemplares similares